Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments

An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola

NCT04268966 ·Status: WITHDRAWN ·Phase: PHASE2

Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults

NCT00708110 ·Status: COMPLETED ·Phase: PHASE2

Multiple Treatments for Ebola Virus Disease (EVD)

NCT02380625 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial

NCT04939311 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Oregon PrEP at Home Study

NCT05949203 ·Status: RECRUITING

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study

NCT00002080 ·Status: COMPLETED ·Phase: NA

A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine

NCT00002274 ·Status: COMPLETED ·Phase: NA

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

NCT00002267 ·Status: COMPLETED ·Phase: NA

A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)

NCT00002170 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals

NCT00002087 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Patients Who Have Not Had Success With Zidovudine

NCT00001025 ·Status: COMPLETED ·Phase: PHASE2

Pre-Exposure Prophylaxis Using TMC278LA

NCT01049932 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients

NCT05224492 ·Status: UNKNOWN ·Phase: PHASE4

Viracept Expanded Access Program

NCT00002165 ·Status: COMPLETED ·Phase: NA

Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection

NCT00239733 ·Status: TERMINATED ·Phase: PHASE4

A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients

NCT00002286 ·Status: COMPLETED ·Phase: NA

A Study of WF 10 IV Solution in Patients With Advanced HIV Disease

NCT00002152 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

NCT00046332 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

NCT00002336 ·Status: COMPLETED ·Phase: NA

A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin

NCT00001989 ·Status: COMPLETED ·Phase: PHASE2

A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus

NCT00000993 ·Status: COMPLETED ·Phase: NA

An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies

NCT00002118 ·Status: COMPLETED ·Phase: NA

Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors

NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers

NCT00110591 ·Status: COMPLETED ·Phase: PHASE1

A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease

NCT00002033 ·Status: COMPLETED ·Phase: NA